Farydak (Panobinostat): First HDAC Inhibitor Approved for Patients with Relapsed Multiple Myeloma.
Lisa A
LA
Raedler
Cancer. 2007 Jun 1;109(11):2334-42
17450591
Br J Haematol. 2013 Mar;160(5):649-59
23293914
Clin Cancer Res. 2013 Jul 1;19(13):3337-44
23515406
Lancet Oncol. 2014 Oct;15(11):1195-206
25242045